Search

Your search keyword '"Blandin S"' showing total 87 results

Search Constraints

Start Over You searched for: Author "Blandin S" Remove constraint Author: "Blandin S"
87 results on '"Blandin S"'

Search Results

51. IL-22BP production is heterogeneously distributed in Crohn's disease.

52. In Situ Regolith Seismic Velocity Measurement at the InSight Landing Site on Mars.

53. [Systemic nocardiosis with mediastinal lymph node involvement proven by endoscopic ultrasound].

54. Lymphoid Organ Proteomes Identify Therapeutic Efficacy Biomarkers Following the Intracavitary Administration of Curcumin in a Highly Invasive Rat Model of Peritoneal Mesothelioma.

55. A Class of Valuable (Pro-)Activity-Based Protein Profiling Probes: Application to the Redox-Active Antiplasmodial Agent, Plasmodione.

56. A role for the succinate dehydrogenase in the mode of action of the redox-active antimalarial drug, plasmodione.

57. Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells-Potential Links with Sarcomas.

58. S100A4 is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma.

59. Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.

60. Investigating the mode of action of the redox-active antimalarial drug plasmodione using the yeast model.

61. Author Correction: Arylmethylamino steroids as antiparasitic agents.

62. Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma.

63. Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma.

64. Arylmethylamino steroids as antiparasitic agents.

65. The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.

66. [Aspergillosis for the pulmonologist].

67. [Thymic tumours, autoimmune neutropaenia and autoimmune haemolytic anaemia].

68. Mosaic genome architecture of the Anopheles gambiae species complex.

69. Structural basis for conserved complement factor-like function in the antimalarial protein TEP1.

70. [Family mesotheliomas: genetic interaction with environmental carcinogenic exposure?].

71. Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes.

72. Malaria Plasmodium agent induces alteration in the head proteome of their Anopheles mosquito host.

73. Boosting NF-kappaB-dependent basal immunity of Anopheles gambiae aborts development of Plasmodium berghei.

74. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection.

75. In vivo identification of novel regulators and conserved pathways of phagocytosis in A. gambiae.

76. [French experience of gefitinib in non-small cell bronchial carcinoma].

77. The solubility and stability of recombinant proteins are increased by their fusion to NusA.

80. Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae.

81. Mosquito immune responses against malaria parasites.

82. Bacterial alpha2-macroglobulins: colonization factors acquired by horizontal gene transfer from the metazoan genome?

83. Silencing of Toll pathway components by direct injection of double-stranded RNA into Drosophila adult flies.

84. Immunity-related genes and gene families in Anopheles gambiae.

85. Reverse genetics in the mosquito Anopheles gambiae: targeted disruption of the Defensin gene.

86. [Isolated pleurisy revealing ovarian hyperstimulation syndrome].

87. Conserved role of a complement-like protein in phagocytosis revealed by dsRNA knockout in cultured cells of the mosquito, Anopheles gambiae.

Catalog

Books, media, physical & digital resources